Results from our third national consumer survey (2017 data) on digital health adoption and sentiments.
To capitalize on the shift to value-based care and consumer demand for a better healthcare experience, a new type of business has emerged: next-generation payers and providers (“NGPPs”). Without the constraints of legacy payment models and operating systems, these companies were created to deliver a reimagined service to patients, prioritizing health and outcomes over utilization. We interviewed five NGPPs to understand their technology-supported strategies, with a focus on how they’ve partnered with startups and how they expect to keep pace with future innovation.
Women are critical stakeholders in healthcare, serving as workers, caregivers, and consumers—yet they do not have an equal voice in the ranks of leadership. Our goal with this annual report is to contribute to a meaningful and actionable dialogue around women in leadership, with the hopes of providing a foundation for our industry to finally turn this dialogue into action.
It’s déjà vu for digital health, with yet another record breaking half for venture funding. The continued upward trajectory from 2017 through the first half of 2018 is not a fluke. Instead, this sustained growth is indicative of the maturation one would expect from a stable, emerging investment sector (coupled with a strong overall venture ecosystem). Read on to learn our five key findings from this eventful half.
On the heels of the biggest year in venture funding, the digital health space is starting off 2018 with a bang: record Q1 funding of $1.62B, three $100M+ mega-deals, and a massive exit. Compared to last year, the commotion from policy debates has largely settled and a path to regulatory clarity has emerged. On our end, we’ve launched a couple of new sections within our funding post—check out our deep investor analysis as well as an update on the sometimes elusive, always critical quest of every digital health company: validation.
AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.
2017 was a record year for digital health by many accounts: total funding far surpassed previous years, there were more investors participating in digital health deals, and we saw more mega deals of $100M+ than ever before. With the industry maturing and entering its “middle innings,” we significantly expanded our Digital Health Funding Database and the information we track on every venture deal and company.
2017 was a record-smashing year for digital health, with venture funding approaching $6B and the most mega deals ($100M+) to date. It’s clear that the early game has concluded and digital health is entering the “middle innings” as an investment sector.
Women are critical stakeholders in healthcare, serving as workers, caregivers, and consumers—yet they do not have an equal voice in the ranks of leadership. Our goal with this report is to contribute to a meaningful and actionable dialogue around women in leadership, with the hopes of providing a foundation for our industry to finally turn this dialogue into action.
For digital health startups, it’s increasingly a B2B world—and innovators are acutely feeling the challenges of enterprise sales. Selling to payers, providers, biopharma companies, and others is a tough game across the board. Sales cycles are long, requiring patience and a knack for relationship building. Finding the right buyer in a big organization can be disorienting. And crafting the pitch is tricky when talking to a complex, multi-faceted enterprise customer.
As the digital health sector matures, investors are putting more money into more deals. In the first half of 2017, $3.5B was invested in 188 digital health companies, setting a record for number of companies funded and total amount invested.
When we started tracking deals in 2011, the newly enacted Affordable Care Act served as a major catalyst for market growth. We’ve only tracked digital health in an ACA-world, so we’ve been on the edge of our seats as the new administration vows to repeal this landmark reform.
2016 was a strong year for digital health, but it also created an environment for discretion and focus for founders and investors alike. There were a record number of companies funded; and while the total amount of dollars decreased from 2015, we remain optimistic in the strength of the sector and the value of the companies improving our healthcare system.
Results from our 2016 digital health consumer adoption survey.
The genomics industry has tremendous potential to move the needle in health. Delivering on the promise of genomics depends on three main factors—many of which are within the purview of digital health. Through our survey of one thousand consumers, we provide novel data and insights regarding adoption, willingness to pay for specific use cases, and explore concerns around privacy and ownership.
After years of record-breaking venture funding, digital health finally hit its stride in a year when everyone expected funding to decline. In the first half of 2016, slightly over $2B filled company coffers–on track with both 2014 and 2015.
In healthcare, big data is only valuable when paired with a strong body of clinical evidence. Digital biomarkers are an opportunity to translate new data sources into informative, actionable insights.
2015 was another year of big numbers for digital health—the year closed out with over $4.5B in funding flooding into the space, a sizable increase in the number of later stage rounds, and 187 M&A deals.
Results from our landmark national survey on the adoption trends in digital health.
A look at the challenges and promises of using new and existing sources of data to deliver personalized care.
A review of the current landscape and future of biosensing wearables.
This report explores why gender diversity matters in healthcare and what we can do to change the status quo.
An in-depth look at the investors, companies, and trends that drove digital health funding in the first half of 2015.
2014 was a record-breaking year. Digital health funding surpassed $4.1B, representing over 125% year-over-year growth.